0 Comentários
0 Compartilhamentos
2K Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de Notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Blogs
-
Marketplace
-
Fóruns
-
Faça Login para curtir, compartilhar e comentar!
-
Colorectal Cancer Treatment Market Expands Globally with Innovations in Targeted Therapies"Executive Summary Colorectal Cancer Treatment Market : CAGR Value The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. This Colorectal Cancer Treatment Market report is structured with the thorough market analysis...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Reviluamide Tablets: A Precision-Targeted New Option for Prostate Cancer TreatmentProstate cancer is one of the most common malignant tumors of the male reproductive system. Among them, metastatic hormone-sensitive prostate cancer (mHSPC) is characterized by rapid disease progression and high treatment complexity, making it a long-standing focus and challenge in clinical practice. As a novel androgen receptor inhibitor independently developed in China, Reviluamide Tablets (...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Urothelial Carcinoma Treatment Market Advances with Immunotherapy and Targeted Drug Innovations"Executive Summary Urothelial Carcinoma Treatment Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses a growth rate in the global urothelial carcinoma treatment market in the forecast period 2023-2030. The expected CAGR of global urothelial carcinoma treatment market is tend to be around 20% in the mentioned forecast period. The market was valued at...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Why the BTK Inhibitor Drug Market Is Transforming Targeted Cancer Treatment"Global Executive Summary BTK Inhibitor Drug Market Market: Size, Share, and Forecast CAGR Value The global BTK inhibitor drug market size was valued at USD 8.73 billion in 2025 and is expected to reach USD 14.88 billion by 2033, at a CAGR of 6.90% during the forecast period The complete BTK Inhibitor Drug Market Market report is spread across a number of...0 Comentários 0 Compartilhamentos 710 Visualizações 0 Anterior
-
Are Immune-Modulating Biologics Redefining the Future of Cancer Immunotherapy?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period The research and analysis...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Are Neoantigen Cancer Vaccines the Next Breakthrough in Personalized Oncology?Executive Summary Neoantigen Cancer Vaccine Therapy Market Market Size and Share Forecast CAGR Value The global neoantigen cancer vaccine therapy market size was valued at USD 986 Million in 2025 and is expected to reach USD 6547.71 Million by 2033, at a CAGR of 26.70% during the forecast period The comprehensive market information and data of...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Are Personalized Cancer Vaccines the Future of Oncology Treatment?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The market...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Are Personalized Cancer Vaccines Transforming the Future of Oncology?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value The market insights gained through this keyword market research analysis report facilitate a more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position a definite brand excellently. With the scrupulous competitor analysis covered in...0 Comentários 0 Compartilhamentos 485 Visualizações 0 Anterior
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comentários 0 Compartilhamentos 643 Visualizações 0 Anterior
-
Can RNA-Based Therapeutics Revolutionize Cancer Treatment?RNA-Based Cancer Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the RNA-Based Cancer Therapeutics Market CAGR Value For structuring the finest market research report like this RNA-Based Cancer Therapeutics Market, a devoted team of experienced forecasters, well-versed analysts and knowledgeable researchers work...0 Comentários 0 Compartilhamentos 36 Visualizações 0 Anterior
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Could Neoantigen Cancer Vaccines Be the Next Breakthrough in Personalized Oncology?Regional Overview of Executive Summary Neoantigen Cancer Vaccine Therapy Market by Size and Share CAGR Value The global neoantigen cancer vaccine therapy market size was valued at USD 986 Million in 2025 and is expected to reach USD 6547.71 Million by 2033, at a CAGR of 26.70% during the forecast period The strategies encompassed in the...0 Comentários 0 Compartilhamentos 938 Visualizações 0 Anterior
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comentários 0 Compartilhamentos 705 Visualizações 0 Anterior
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comentários 0 Compartilhamentos 693 Visualizações 0 Anterior
Páginas Impulsionadas
Patrocinado
Patrocinado
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek